Abstract
The development of new phamacological treatments for obesity has been challenging. In part, the lack of early diagnosis, earlydetection, early intervention and treatment has meant that more cases progress to life-threatening co-morbidities and surgical options.Pharmacological treatment of obesity has been limited. Self medication with drugs of abuse and tobacco has been successful for some patients,but abuse and addiction make this approach quite dangerous. The advent of trendy 'diets du jour' has apparently made obesity andeating disorders more likely rather than less likely. Trials of novel anti-obesity compounds have generally compared the new medicationand placebo to a dietary counseling intervention. Interventions for patients who are not obese enough for gastric banding or bariatric surgeryare quite similar to those given to alcoholics in the 1970s, "drink less or stop drinking". We need to consume less in a modern life ofdesk and computer work, driving, and even internet shopping. However, we are driven and reinforced to consume and easily fall prey totelevision and other cues and messages driving this relationship to eating. This paper, after briefly reviewing the consensus on consumptionand exercising suggests that new treatments may be developed by increasing exercise adherence and even increasing the reinforcingvalue or power of exercise itself. Food, sex, and drugs of abuse are highly valued and reinforced in our brains, so why not exercise?.
| Original language | English |
|---|---|
| Pages (from-to) | 1193-1197 |
| Number of pages | 5 |
| Journal | Current Pharmaceutical Design |
| Volume | 17 |
| Issue number | 12 |
| DOIs | |
| State | Published - 2011 |
Keywords
- Aerobic
- Anorexia
- Exercise
- Globesity
- Obesity
- Resistance
Fingerprint
Dive into the research topics of 'Exercise for the overweight and obese'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver